Literature DB >> 21568229

Thyroid cancer: what to do after fine needle aspiration.

David A Rometo1, Thomas J Baranski.   

Abstract

The incidence of differentiated thyroid cancer (including papillary, follicular, and Hurthle cell carcinoma) has nearly tripled in the past 20 years. Diagnosis, treatment, and long-term management are evolving with advances in radiology, surgical techniques, nuclear medicine, genetics, and targeted therapeutics. Here we detail the current recommended course of action for differentiated thyroid cancer and options on the horizon.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21568229      PMCID： PMC6189162     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  10 in total

1.  The effect of posttherapy 131I SPECT/CT on risk classification and management of patients with differentiated thyroid cancer.

Authors:  Ravinder K Grewal; R Michael Tuttle; Joseph Fox; Sunita Borkar; Joanne F Chou; Mithat Gonen; H William Strauss; Steven M Larson; Heiko Schöder
Journal:  J Nucl Med       Date:  2010-08-18       Impact factor: 10.057

2.  BRAF in primary and recurrent papillary thyroid cancers: the relationship with (131)I and 2-[(18)F]fluoro-2-deoxy-D-glucose uptake ability.

Authors:  Susi Barollo; Gianmaria Pennelli; Federica Vianello; Sara Watutantrige Fernando; Isabella Negro; Isabella Merante Boschin; Maria Rosa Pelizzo; Massimo Rugge; Franco Mantero; Davide Nacamulli; Maria Elisa Girelli; Benedetto Busnardo; Caterina Mian
Journal:  Eur J Endocrinol       Date:  2010-07-20       Impact factor: 6.664

Review 3.  Targeting vascular endothelial growth factor receptor in thyroid cancer: the intracellular and extracellular implications.

Authors:  Stephen M Keefe; Marc A Cohen; Marcia S Brose
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

4.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  Sunitinib inhibits MEK/ERK and SAPK/JNK pathways and increases sodium/iodide symporter expression in papillary thyroid cancer.

Authors:  Mike S Fenton; Kenneth M Marion; Andrew K Salem; Rachel Hogen; Faramarz Naeim; Jerome M Hershman
Journal:  Thyroid       Date:  2010-09       Impact factor: 6.568

6.  Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.

Authors:  M Dietlein; K Scheidhauer; E Voth; P Theissen; H Schicha
Journal:  Eur J Nucl Med       Date:  1997-11

Review 7.  The value of positron emission tomography (PET) in the management of patients with thyroid cancer.

Authors:  Richard J Robbins; Steven M Larson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-12       Impact factor: 4.690

8.  Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.

Authors:  Steven E Finkelstein; Perry W Grigsby; Barry A Siegel; Farrokh Dehdashti; Jeffrey F Moley; Bruce L Hall
Journal:  Ann Surg Oncol       Date:  2007-09-20       Impact factor: 5.344

9.  Well-differentiated thyroid carcinoma: comparison of microscopic and macroscopic disease.

Authors:  Gloria Tzvetov; Dania Hirsch; Ilana Shraga-Slutzky; Ruth Weinstein; Yosi Manistersky; Ronit Kalmanovich; Mordechai Lapidot; Simona Grozinsky-Glasberg; Joelle Singer; Jaqueline Sulkes; Ilan Shimon; Carlos Benbassat
Journal:  Thyroid       Date:  2009-05       Impact factor: 6.568

10.  Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

Authors:  Yuri E Nikiforov; David L Steward; Toni M Robinson-Smith; Bryan R Haugen; Joshua P Klopper; Zhaowen Zhu; James A Fagin; Mercedes Falciglia; Katherine Weber; Marina N Nikiforova
Journal:  J Clin Endocrinol Metab       Date:  2009-03-24       Impact factor: 5.958
  10 in total
  1 in total

1.  Relationship between negative mental adjustment to cancer and distress in thyroid cancer patients.

Authors:  Jeong-Ho Seok; Won-Jung Choi; Yong Sang Lee; Cheong Soo Park; Young-Ja Oh; Jong-Sun Kim; Hang-Seok Chang
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.